<DOC>
	<DOCNO>NCT00635609</DOCNO>
	<brief_summary>Randomized , multi-center , open label , active-comparator study compare efficacy tolerability Doryx Delayed Release Tablets doxycycline hyclate patient moderate severe acne vulgaris .</brief_summary>
	<brief_title>Treatment Acne Vulgaris With Doryx Tablets Compared Doxycyline Hyclate</brief_title>
	<detailed_description>Efficacy Doryx Delayed Release Tablets doxycycline hyclate assess use Investigator 's Global Assessment ( IGA ) score absolute change baseline 12 week inflammatory lesion count patient moderate severe facial acne vulgaris . Additionally , absolute change baseline 12 week non-inflammatory lesion count Doryx Delayed Release Tablets compare doxycycline hyclate evaluate .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Must 12 year age older . Has diagnosis facial acne vulgaris two nodule face . Is allergic tetracyclineclass antibiotic ingredient study medication . Has history pseudomembranous colitis antibioticassociated colitis . Has history hepatitis liver damage renal impairment .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>